Ozempic vs Wegovy
Ozempic
GLP-1 receptor agonist for diabetes and weight management with established clinical data.
Type 2 diabetic patients seeking improved glucose control with the added benefit of weight loss
VS
Wegovy
Higher-dose semaglutide injection specifically approved for chronic weight management and obesity treatment.
Obese or overweight individuals (BMI ≥30 or ≥27 with weight-related comorbidities) whose primary goal is significant weight loss
Short Answer
Ozempic and Wegovy are both semaglutide medications but differ primarily in their FDA-approved indication: Ozempic treats type 2 diabetes while Wegovy is approved for chronic weight management in obese or overweight patients. Wegovy uses higher doses and is marketed specifically for weight loss, whereas Ozempic's weight loss is a secondary benefit.
Our Verdict
Both medications contain the same active ingredient (semaglutide) and are highly effective, but serve different primary purposes. Ozempic is the better choice for type 2 diabetes patients seeking diabetes control with weight loss as a bonus, while Wegovy is superior for individuals whose primary goal is significant weight management. Choice should align with medical needs, insurance coverage, and physician guidance.
Ozempic7.5
7.5Wegovy
Choose Ozempic if
Type 2 diabetic patients seeking improved glucose control with the added benefit of weight loss
Track this comparison
Get notified when prices change, new specs ship, or our verdict updates.
Triggers: price change new spec verdict update
No spam. Stop anytime.
Key Differences at a Glance
🔹
Primary FDA Approval: Type 2 Diabetes vs Chronic Weight Management
🔹
Maximum Approved Dose: Wegovy wins (2.4 mg weekly vs 2.0 mg weekly)
⚖️
Average Weight Loss: Wegovy wins (15-22% body weight vs 5-7% body weight)
Key Facts & Figures
| Metric | Ozempic | Wegovy | Diff |
|---|---|---|---|
| Monthly Cost (without insurance)(USD) | ~$900 | ~$1,300 | -31% |
| Maximum Weekly Dose(mg) | 2.0 mg | 7.2 mg (HD formulation) | -72% |
| FDA Approval Year(year) | 2017 |
Key Differences
Ozempic
Attribute
Wegovy
Type 2 Diabetes
Primary FDA Approval
Chronic Weight Management
2.0 mg weekly
Maximum Approved Dose
2.4 mg weekly🏆
5-7% body weight
Average Weight Loss
15-22% body weight🏆
Related Comparisons
W
O
Wegovy vs Ozempic
health
W
O
Wegovy vs Ozempic
products
O
M
Ozempic vs Mounjaro
health
T
A
Tylenol vs Advil
health
A
O
Almond Milk vs Oat Milk
health
V
V
Vegan vs Vegetarian
health
K
P
Keto vs Paleo
health
R
W
Running vs Walking
health
Y
P
Yoga vs Pilates
health
F
C
Flu Shot vs COVID Vaccine
health
O
N
Organic Food vs Non-Organic Food
health
T
M
Therapy vs Medication
health
Related Articles
Explore Entities
More Health & Wellness
Last updated: May 23, 2026AI generated
